Comprehensive effects of Parkinson's disease multimodal complex treatment (PD-MCT): a two-center prospective trial
Abstract
Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms that impair quality of life. Inpatient Parkinson's disease Multimodal Complex Treatment (PD-MCT) integrates individualized medication adjustments with intensive multiprofessional therapies and improves symptoms and functional abilities. However, evidence remains limited regarding which symptom domains benefit most and which patient characteristics predict treatment response, particularly in advanced PD and with respect to cognitive status.
Methods: This two-center, prospective cohort study included 53 adults with advanced idiopathic PD who underwent 14-21 days of inpatient PD-MCT at two centers. Inclusion criteria comprised a diagnosis of PD according to German and International Parkinson and Movement Disorder Society guidelines and the ability to walk at least 50 m with assistive devices. Patients with atypical parkinsonian syndromes or comorbidities severely affecting gait were excluded. Motor function, non-motor symptoms, cognition, and quality of life were assessed at baseline and before discharge. A 3-month follow-up evaluated symptom burden and continuation of supportive therapies. Primary outcomes were changes in motor symptom severity (ΔMDS-UPDRS-III), overall motor function (ΔMDS-UPDRS-II + III + IV), and quality of life (ΔPDQ-39).
Results: PD-MCT significantly improved motor symptom severity (-5.2 ± 10.6), overall motor function (-10.6 ±…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 53 participants or records.
Read the paper
Related studies
- A Survey on Knowledge Graphs: Representation, Acquisition, and Applications
- Toxicity of nanomaterials
- The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
- Halogen bonding (X‐bonding): A biological perspective
- Biofilm formation at the air–liquid interface by the Pseudomonas fluorescens SBW25 wrinkly spreader requires an acetylated form of cellulose
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.